Project A Randomized, Open label, Phase 3 Study in Subjects with Relapsed and Refractory Multiple Myeloma Receiving…

Basic data

Title:
A Randomized, Open label, Phase 3 Study in Subjects with Relapsed and Refractory Multiple Myeloma Receiving Carfilzomib in Combination with Dexamethasone, Comparing Once weekly versus Twice weekly Carfilzomib Dosing
Duration:
01/08/2015 to 31/07/2018
Abstract / short description:
A Randomized, Open label, Phase 3 Study in Subjects with Relapsed and Refractory Multiple Myeloma Receiving Carfilzomib in Combination with Dexamethasone, Comparing Once weekly versus Twice weekly Carfilzomib Dosing
Keywords:
clinical trial
klinische Studie

Involved staff

Managers

Faculty of Medicine
University of Tübingen

Local organizational units

Department of Diagnostic and Interventional Radiology
Department of Radiology
Hospitals and clinical institutes, Faculty of Medicine

Funders

Mannheim, Baden-Württemberg, Germany
Help

will be deleted permanently. This cannot be undone.